Cargando…

Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort

BACKGROUND: To address human resource and infrastructure shortages, resource-constrained countries are being encouraged to shift HIV care to lesser trained care providers and lower level health care facilities. This study evaluated the cost-effectiveness of down-referring stable antiretroviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Lawrence, Brennan, Alana, Fox, Matthew P., Ndibongo, Buyiswa, Jaffray, Imogen, Sanne, Ian, Rosen, Sydney
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139666/ https://www.ncbi.nlm.nih.gov/pubmed/21811402 http://dx.doi.org/10.1371/journal.pmed.1001055

Ejemplares similares

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa
por: Larson, Bruce, et al.
Publicado: (2012)

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa
por: Larson, Bruce A, et al.
Publicado: (2010)

Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment
por: Rosen, Sydney, et al.
Publicado: (2010)

Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data
por: Rosen, Sydney, et al.
Publicado: (2011)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough
por: Larson, Bruce A., et al.
Publicado: (2013)

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Retention in care and viral suppression after same‐day ART initiation: One‐year outcomes of the SLATE I and II individually randomized clinical trials in South Africa
por: Maskew, Mhairi, et al.
Publicado: (2021)

Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
por: Takuva, Simbarashe, et al.
Publicado: (2013)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa
por: Brennan, Alana T., et al.
Publicado: (2018)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa
por: Brennan, Alana T, et al.
Publicado: (2013)

Prevalence of TB symptoms, diagnosis and treatment among people living with HIV (PLHIV) not on ART presenting at outpatient clinics in South Africa and Kenya: baseline results from a clinical trial
por: Brennan, Alana, et al.
Publicado: (2020)

The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa
por: Brennan, Alana T, et al.
Publicado: (2010)

Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis
por: Larson, Bruce A., et al.
Publicado: (2021)

Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa
por: Onoya, Dorina, et al.
Publicado: (2016)

A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial
por: Maskew, Mhairi, et al.
Publicado: (2020)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Who is seeking antiretroviral treatment for HIV now? Characteristics of patients presenting in Kenya and South Africa in 2017‐2018
por: Brennan, Alana T, et al.
Publicado: (2019)

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2018)

Incidence of Pregnancy after Initiation of Antiretroviral Therapy in South Africa: A Retrospective Clinical Cohort Analysis
por: Westreich, Daniel, et al.
Publicado: (2012)

Cohort profile: the Right to Care Clinical HIV Cohort, South Africa
por: Fox, Matthew P, et al.
Publicado: (2017)

Change in body weight and risk of hypertension after switching from efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa
por: Brennan, Alana T., et al.
Publicado: (2023)

Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya
por: Rosen, Sydney, et al.
Publicado: (2019)

Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa
por: Fox, Matthew P., et al.
Publicado: (2014)

Will differentiated care for stable HIV patients reduce healthcare systems costs?
por: Larson, Bruce A, et al.
Publicado: (2020)

Patient Perspectives of Quality of the Same-Day Antiretroviral Therapy Initiation Process in Gauteng Province, South Africa: Qualitative Dominant Mixed-Methods Analysis of the SLATE II Trial
por: Scott, Nancy A., et al.
Publicado: (2020)

Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa
por: Moyo, Faith, et al.
Publicado: (2016)

Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort
por: Takuva, Simbarashe, et al.
Publicado: (2014)

Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care
por: Maskew, Mhairi, et al.
Publicado: (2018)

Brief Report: Does Most Mortality in Patients on ART Occur in Care or After Lost to Follow-Up? Evidence From the Themba Lethu Clinic, South Africa
por: Budgell, Eric P., et al.
Publicado: (2015)

Health systems performance for hypertension control using a cascade of care approach in South Africa, 2011–2017
por: Benade, Mariet, et al.
Publicado: (2023)

Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa
por: Rosen, Sydney, et al.
Publicado: (2010)

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
por: Berhanu, Rebecca, et al.
Publicado: (2016)

Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
por: Benade, Mariet, et al.
Publicado: (2022)

Factors influencing the information behaviour of doctors and nurses in South Africa’s Eastern Cape, Mpumalanga, Limpopo and Northern Cape provinces: a survey study protocol
por: Chitha, Nombulelo, et al.
Publicado: (2022)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5cdhhurials2u3hv1ki91q2o1o